Berkeley Lights, Inc. (BLI)

Market Cap	167.34M
Revenue (ttm)	83.94M
Net Income (ttm)	-86.47M
Shares Out	68.86M
EPS (ttm)	-1.29
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	802,154
Open	2.30
Previous Close	2.36
Day's Range	2.27 - 2.51
52-Week Range	1.83 - 9.03
Beta	1.45
Analysts	Buy
Price Target	10.46 (+330.45%)
Earnings Date	Feb 23, 2023

About BLI

Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It serves in North America, the Asia Pacific, and Europe. Berkeley Lights, Inc. was incorporated in 2011 and is headquartered in Emeryville, California.

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Jul 17, 2020
• Employees: 293
• Stock Exchange: NASDAQ
• Ticker Symbol: BLI

Financial Performance

In 2021, BLI's revenue was $85.39 million, an increase of 32.79% compared to the previous year's $64.30 million. Losses were -$71.72 million, 72.5% more than in 2020.

Analyst Forecast

According to 11 analysts, the average rating for BLI stock is "Buy." The 12-month stock price forecast is $10.46, which is an increase of 330.45% from the latest price.

Price Target

$10.46

(330.45% upside)

Analyst Consensus: Buy